Acute treatment of migraine in children and adolescents

Functional Neurology

Volumn 23, Issue 2, 2008, Pages 63-69

  Termine, Cristiano ^a,b,e   Ferri, Matteo ^a,b   Balottin, Umberto ^b,c,d  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Polyclinic of Monza   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e Ospedale F del Ponte   (Italy)

Author keywords

Acute treatment; Adolescence; Childhood; Migraine; Review

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; DICLOFENAC; DIHYDROERGOTAMINE; ELETRIPTAN; IBUPROFEN; MEFENAMIC ACID; NAPROXEN; PARACETAMOL; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

ANALGESIA; ANAPHYLAXIS; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; KIDNEY FAILURE; LIVER TOXICITY; MIGRAINE; NEPHROTOXICITY; REVIEW; TASTE DISORDER; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ADOLESCENT; AGE OF ONSET; ANALGESICS; CHILD; HUMANS; MIGRAINE DISORDERS; TRYPTAMINES;

EID: 50849132947     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Lipton RB, Bigal ME, Stewart WF. Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology 2005;65(Suppl 4):S50-S58
2. Tfelt-Hansen P. Acute pharmacotherapy of migraine, tension-type headache, and cluster headache. J Headache Pain 2007;8:127-133
3. Wöber C, Wöber-Bingöl C. Clinical management of young patients presenting with headache. Funct Neurol 2000;15 (Suppl 3):89-105
4. Agostoni E, Rigamonti A. Migraine and cerebrovascular disease. Neurol Sci 2007;28(Suppl 2):S156-S160
5. Mortimer MJ, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia 1992;12:238-243
6. Wöber-Bingöl C, Wöber C, Karwautz A et al. Diagnosis of headache in childhood and adolescence: a study in 437 patients. Cephalalgia 1995;15:13-21
7. Lanzi G, Balottin U, Fazzi E, Tagliasacchi M, Manfrin M, Mira E. Benign paroxysmal vertigo of childhood: a long-term follow-up. Cephalalgia 1994;14:458-460
8. Stafstrom CE, Goldenholz SR, Dulli DA. Serial headache drawings by children with migraine: correlation with clinical headache status. J Child Neurol 2005;20:809-813
9. Prensky AL, Sommer D. Diagnosis and treatment of migraine in children. Neurology 1979;29:506-510
10. Lanzi G, Balottin U. The semeiology of migraine attacks in childhood. In: Occipital Seizures and Epilepsies in Children. Mariani Foundation Pediatric Neurology Series - 1. London; John Libbey 1993:87-91
11. Winner P, Martinez W, Mate L, Bello L. Classification of pediatric migraine: proposed revisions to the IHS criteria. Headache 1995;35:407-410
12. Balottin U, Borgatti R, Zambrino CA, Lanzi G. Clinical characteristics and long-term outcome of migraine with aura in children and adolescents. Dev Med Child Neurol 1997;39:26-30
13. Lanzi G, Balottin U, Zambrino CA et al. Guidelines and recommendations for the treatment of migraine in paediatric and adolescent patients. Italian Society for the Study of Headache. Funct Neurol 1996;11: 269-275
14. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1-96
15. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(Suppl 1):9-160
16. Balottin U, Termine C, Nicoli F, Quadrelli M, Ferrari-Ginevra O, Lanzi G. Idiopathic headache in children under six years of age: a follow-up study. Headache 2005;45:705-715
17. Arruda MA, Bordini CA, Ciciarelli JC et al. Decreasing the minimal duration of the attack to 1 hour: is this sufficient to increase the sensitivity of the ICHD-II for migraine in childhood? J Headache Pain 2004;5:131-136
18. Balottin U, Termine C. Recommendations for the management of migraine in paediatric patients. Expert Opin Pharmacother 2007;8:731-744
19. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-762
20. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK. Neurobiological mechanisms of the placebo effect. J Neurosci 2005;25:10390-10402
21. Silberstein SD, Saper JR, Freitag FG. Migraine: diagnosis and treatment. In: Silberstein SD, Lipton RB, Dalessio DJ eds Wolff's Headache and Other Head Pain, 7th edition. New York; Oxford University Press 2001: 98-115
22. Piletta P, Porchet HC, Dayer P. Central analgesic effect of acetaminophen but not of aspirin. Clin Pharmacol Ther 1991;49:350-354
23. Pelissier T, Alloui A, Caussade F et al. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence. J Pharmacol Exp Ther 1996;278:8-14
24. Raffa RB, Codd EE. Lack of binding of acetaminophen to 5-HT receptor or uptake sites (or eleven other binding/uptake assays). Life Sci 1996;59:PL37-40
25. Buzzi MG, Sakas DE, Moskowitz MA. Indomethacin and acetylsalicyclic acid block neurogenic plasma protein extravasation in rat dura mater. Eur J Pharmacol 1989;165:251-258
26. Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 1997;48:103-107
27. Lewis DW, Kellstein D, Dahl G et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache 2002;42:780-786
28. Evers S, Rahmann A, Kraemer C et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology 2006;67:497-499.
29. Boyle R, Behan PO, Sutton JA. A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharmacol 1990;30:405-409.
30. Silberstein SD, Young WB. Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology. Neurology 1995;45:577-584
31. Hämäläinen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology 1997;48:1100-1103
32. Hämäläinen ML, Hoppu K, Santavuori PR. Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatr Neurol 1997;16:114-117
33. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 1994;34:581-582
34. Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice. Headache 1996;36:419-422
35. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 1999;52:1507-1510
36. Winner P, Rothner AD, Saper J et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000;106:989-997
37. Ahonen K, Hämäläinen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology 2004;62:883-887
38. Winner P, Rothner AD, Wooten JD, Webster C, Ames M. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache 2006;46:212-222
39. Winner P, Lewis D, Visser WH et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind placebo-controlled study. Headache 2002;42:49-55
40. Visser WH, Winner P, Strohmaier K et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache 2004;44:891-899
41. Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in adolescents. Int J Clin Pract 2000;54:466-469
42. Charles JA. Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety. J Headache Pain 2006;7:95-97
43. Christensen ML, Eades SK, Fuseau E, Kempsford RD, Phelps SJ, Hak LJ. Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine. J Clin Pharmacol 2001;41:170-175
44. Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Headache 2007;47:511-518
45. Karwautz A, Wöber C, Lang T et al. Psychosocial factors in children and adolescents with migraine and tension-type headache: a controlled study and review of the literature. Cephalalgia 1999;19:32-43.
46. Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression: is the association specific to migraine? Neurology 2000;54:308-313
47. Lanzi G, Zambrino CA, Ferrari-Ginevra O et al. Personality traits in childhood and adolescent headache. Cephalalgia 2001;21:53-60.
48. Anttila P, Sourander A, Metsähonkala L, Aromaa M, Helenius H, Sillanpää M. Psychiatric symptoms in children with primary headache. J Am Acad Child Adolesc Psychiatry 2004;43:412-419
49. Bandell-Hoekstra I, Abu-Saad HH, Passchier J, Knipschild P. Recurrent headache, coping, and quality of life in children: a review. Headache 2000;40:357-370
50. Masi G, Favilla L, Millepiedi S, Mucci M. Somatic symptoms in children and adolescents referred for emotional and behavioral disorders. Psychiatry 2000;63:140-149
51. Sacco S, Carolei A. Migraine attributed to genetic disorder. Funct Neurol 2007;22:117-118